Chaldakov [11] has previously found that circulating BDNF levels are decreased in subjects with advanced metabolic syndrome, whereas BDNF levels are elevated in subjects in the early stages of metabolic disturbances. This evidence concerns the gene BDNF and metabolic syndrome.